Enzo Biochem Net Income
| ENZDelisted Stock | USD 0.54 0.01 1.89% |
As of the 14th of February 2026, Enzo Biochem shows the Mean Deviation of 4.58, coefficient of variation of 1554.3, and Downside Deviation of 7.74. Enzo Biochem technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Enzo Biochem's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Enzo Biochem's valuation are provided below:Enzo Biochem does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Enzo |
Search Suggestions
| E | Eni SpA ADR | Company |
| EFSCP | Enterprise Financial Services | Company |
| EAD | Allspring Income Opportunities | Fund |
| EU | enCore Energy Corp | ETF |
| EMCLOUD | BVP Nasdaq Emerging | Index |
| EM | EM | Cryptocurrency |
| E0R75RAB2 | AICNRA 575 15 JUN 33 | Corporate Bond |
| ESUSD | E Mini SP 500 | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Enzo Biochem reported net income of (26.08 Million). This is 107.64% lower than that of the Health Care Providers & Services sector and 115.06% lower than that of the Health Care industry. The net income for all United States stocks is 104.57% higher than that of the company.
Enzo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzo Biochem's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enzo Biochem could also be used in its relative valuation, which is a method of valuing Enzo Biochem by comparing valuation metrics of similar companies.Enzo Biochem is currently under evaluation in net income category among its peers.
Enzo Fundamentals
| Return On Equity | -0.13 | |||
| Return On Asset | -0.0746 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.22) % | |||
| Current Valuation | (5.4 M) | |||
| Shares Outstanding | 52.4 M | |||
| Shares Owned By Insiders | 21.68 % | |||
| Shares Owned By Institutions | 34.78 % | |||
| Number Of Shares Shorted | 364.9 K | |||
| Price To Earning | 26.60 X | |||
| Price To Book | 0.65 X | |||
| Price To Sales | 0.57 X | |||
| Revenue | 31.91 M | |||
| Gross Profit | 13.02 M | |||
| EBITDA | (8.35 M) | |||
| Net Income | (26.08 M) | |||
| Cash And Equivalents | 82.37 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 2.21 X | |||
| Book Value Per Share | 0.89 X | |||
| Cash Flow From Operations | (26.26 M) | |||
| Short Ratio | 2.70 X | |||
| Earnings Per Share | (0.14) X | |||
| Target Price | 5.5 | |||
| Number Of Employees | 125 | |||
| Beta | 1.16 | |||
| Market Capitalization | 16.44 M | |||
| Total Asset | 85.76 M | |||
| Retained Earnings | (294.43 M) | |||
| Working Capital | 45.24 M | |||
| Current Asset | 91.4 M | |||
| Current Liabilities | 20.57 M | |||
| Annual Yield | 1.25 % | |||
| Net Asset | 85.76 M | |||
| Last Dividend Paid | 0.1 |
About Enzo Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enzo Biochem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzo Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzo Biochem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Enzo Stock
If you are still planning to invest in Enzo Biochem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzo Biochem's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |